Lipid microarrays identify key mediators of autoimmune brain inflammation

被引:240
作者
Kanter, JL
Narayana, S
Ho, PP
Catz, I
Warren, KG
Sobel, RA
Steinman, L
Robinson, WH
机构
[1] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[4] Univ Alberta, Dept Med, Edmonton, AB, Canada
[5] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[6] Palo Alto VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA
关键词
D O I
10.1038/nm1344
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies suggest that increased T-cell and autoantibody reactivity to lipids may be present in the autoimmune demyelinating disease multiple sclerosis. To perform large-scale multiplex analysis of antibody responses to lipids in multiple sclerosis, we developed microarrays composed of lipids present in the myelin sheath, including ganglioside, sulfatide, cerebroside, sphingomyelin and total brain lipid fractions. Lipid-array analysis showed lipid-specific antibodies against sulfatide, sphingomyelin and oxidized lipids in cerebrospinal fluid (CSF) derived from individuals with multiple sclerosis. Sulfatide-specific antibodies were also detected in SJL/J mice with acute experimental autoimmune encephalomyelitis (EAE). Immunization of mice with sulfatide plus myelin peptide resulted in a more severe disease course of EAE, and administration of sulfatide-specific antibody exacerbated EAE. Thus, autoimmune responses to sulfatide and other lipids are present in individuals with multiple sclerosis and in EAE, and may contribute to the pathogenesis of autoimmune demyelination.
引用
收藏
页码:138 / 143
页数:6
相关论文
共 32 条
[1]   LIPID ALTERATIONS IN APPARENTLY NORMAL WHITE MATTER IN MULTIPLE SCLEROSIS [J].
ALLING, C ;
VANIER, MT ;
SVENNERHOLM, L .
BRAIN RESEARCH, 1971, 35 (02) :325-+
[2]  
Battistini L, 1996, J NEUROIMMUNOL, V67, P145
[3]   Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease [J].
Bjartmar, C ;
Wujek, JR ;
Trapp, BD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) :165-171
[4]   CD1 expression is differentially regulated by microglia, macrophages and T cells in the central nervous system upon inflammation and demyelination [J].
Busshoff, U ;
Hein, A ;
Iglesias, A ;
Dörries, R ;
Régnier-Vigouroux, A .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 113 (02) :220-230
[5]  
Cipriani B, 2003, BRAIN PATHOL, V13, P1
[6]   LIPID CHEMISTRY OF THE BRAIN IN DEMYELINATING DISEASES [J].
CUMINGS, JN .
BRAIN, 1955, 78 (04) :554-563
[7]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[8]   The role of antiglycolipid antibodies in neurological disorders [J].
Fredman, P .
SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 :341-352
[9]   Identification of autoantibodies associated with myelin damage in multiple sclerosis [J].
Genain, CP ;
Cannella, B ;
Hauser, SL ;
Raine, CS .
NATURE MEDICINE, 1999, 5 (02) :170-175
[10]   BRAIN LIPIDS IN MULTIPLE SCLEROSIS AND OTHER DISEASES [J].
GERSTL, B ;
SMITH, JK ;
TAVASTSTJERNA, MG ;
HAYMAN, RB ;
KAHNKE, MJ .
BRAIN, 1961, 84 (02) :310-+